Tredegar Corporation(TG)Earnings, Financials & Key RatiosTredegar Corporation (TG) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
the company's inability to maintain consistent profitability, highlighted by a 3.0% net margin in 2026Q1 and recurring negative free cash flow, suggests significant operational risk despite recent deleveraging efforts.
Tredegar Corporation (TG) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Tredegar Corporation (TG) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 8, 2026 | $0.15 | $186M |
| Q2 2026 | Mar 11, 2026 | $0.32 | $184M |
| Q4 2025 | Nov 7, 2025 | $0.26 | $195M |
| Q3 2025 | Aug 8, 2025 | $0.05 | $179M |
Recent stock market news and headlines for Tredegar Corporation (TG)
[url="]Ionis Pharmaceuticals, Inc.[/url] (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has approved TRYNGOLZAÂ (olezarsen) a
NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES AND NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES VANCOUVER, BC / ACCESS Newswire / June 17, 2026 / Trifecta Gold Ltd. (TSXV:TG)(OTCQB:TRRFF) ("Trifecta" or the "Company") announces that further to its news release dated June 15, 2026, the Company has increased its previously announced Private Placement of Flow-through shares to consist of the sale of up to 5,750,000 Flow-through shares at a price of $0.20 per Flow-through share.
Key metrics vs top competitors for Tredegar Corporation (TG)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $7.77 | $271.16M | 8.09 | 20.88% | 4.63% | 16.84% | — | |
| $45.18 | $4.77B | 16.73 | 10.73% | 4.31% | 12.47% | — | |
| $42.15 | $6.21B | 12.29 | -0.61% | 9.43% | 48.39% | — | |
| $85.44 | $4.85B | 17.09 | -4.99% | 4.27% | 8.41% | — | |
| $247.20 | $5.14B | 69.05 | 6.05% | 3.99% | 8.17% | — | |
| $10.97 | $1.91B | -6.90 | -5.85% | -5.69% | -8.14% | — |
Tredegar Corporation (TG) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Tredegar Corporation (TG) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 13, 2026·SEC
May 8, 2026·SEC
Mar 11, 2026·SEC
Get notified when TG posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Tredegar Corporation (TG) stock FAQ — growth, dividends, profitability & financials explained
Tredegar Corporation (TG) reported $744.6M in revenue for fiscal year 2025. This represents a 42% increase from $523.6M in 1996.
Tredegar Corporation (TG) grew revenue by 20.9% over the past year. This is strong growth.
Yes, Tredegar Corporation (TG) is profitable, generating $29.0M in net income for fiscal year 2025 (4.6% net margin).
Tredegar Corporation (TG) has a return on equity (ROE) of 16.8%. This is reasonable for most industries.
Tredegar Corporation (TG) generated $20.5M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
